How Much Quizartinib for FLT3 Mutation AML?

So, Quizartinib is a FLT3 inhibitor. It’s used for AML, particularly in cases that come back or don’t respond to treatment, and it’s most effective against FLT3-ITD mutations. It blocks FLT3 signaling, that’s the main thing it does.

The standard dose is 53 mg a day, but you’ve got to start off easy, then ramp up. They offer two tablet strengths, 17.7 mg and 26.5 mg, to start. Each dose is about three tablets worth, give or take.

You’ll find it in bottles with 28 of those coated tablets.